Search results for " Medical treatment"
showing 6 items of 6 documents
The Use of Medicinal Clay from Silesia “Terra sigillata Silesiaca”, Central Europe - A New Chance for Natural Medicine?
2019
Silesia is a region in Central Europe with beneficial conditions for the presence of clay, including those with potential therapeutic efficacies, due to its very diverse and mosaic geological landscape. The first use of clay deposits in medicine in Silesia, “terra sigillata Silesiaca”, has been dated to 1550 AD, and the oldest written information related to this use has been dated to 1586 AD. Medicinal clay is formed by the accumulation of a mixture of minerals such as smectite, bentonite, montmorillonite, kaolinite, illite, and metahaloisite, with impurities of other minerals and fractions, resulting from the chemical weathering of rocks and the sedimentation of detritus. The quantitative …
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”
2019
A phase III study has demonstrated that 6-month pasireotide treatment induced disease control with good safety in 15–26% of patients with Cushing’s disease (CD). The aim of the current study was to evaluate the 6-month efficacy and safety of pasireotide treatment according to the real-world evidence. Thirty-two CD patients started pasireotide at the dose of 600 µg twice a day (bid) and with the chance of up-titration to 900 µg bid, or down-titration to 450 or 300 µg bid, on the basis of urinary cortisol (UC) levels or safety. Hormonal, clinical and metabolic parameters were measured at baseline and at 3-month and 6-month follow-up, whereas tumour size was evaluated at baseline and at 6-mont…
Il consenso informato ai trattamenti sanitari sui minori e decisioni di fine vita. Riflessioni comparatistiche
2019
The essay deals with the informed consent to allow or to refuse medical treatment for pediatric patients, in a comparative law perspective. The first part focuses on the principle of personal autonomy and the rights to health and to life for patiens who lack capacity, as enshrined in Italian legislation. In determining care and treatment in relation to their child, parents have to take into account the physical and mental well-being, life and dignity of the person, as fully as possible (art. 3, L. 219/2017). The second part of the paper investigates the consequences of parents' refusal to interrupt or continue life-sustaining treatment in relation to infants suffering from serious and incur…
Psoriatic arthritis and COVID ‐19 pandemic: Consequences in medical treatment?
2020
The COVID‐19 pandemic has a strong negative impact on human society world‐wide. Patients with immune‐mediated disease may be prone to an increased risk of infection and/ or more severe course. We review the available data for patients with psoriatic arthritis (PSA) and systemic treatments. Current treatment options are summarized. Based upon the experience with COVID‐19 the following problems are addressed: (a) Can systemic treatment reduce comorbidities of PsA that are also comorbidities for COVID‐19? Does systemic medical treatment pose an increased risk of infection with SARS‐CoV‐2? Does systemic drug therapy have an impact on the risk of pulmonary fibrosis ‐ a factor with strong negativ…
RIFLESSIONI COMPARATISTICHE A MARGINE DELLE SCELTE IN TEMA DI TRATTAMENTO SANITARIO
2018
The essay deals with advance directives to allow or to refuse medical treatment, specifically when the person is in a situation of incapacity. The first part focuses the notion of human dignity in connection with the idea of individual autonomy as right to personal identity and as right to health. The second part of the essay is dedicated to the more remarkable parts of Italian legislation (l. 219/ 2017) that enables someone aged 18 and over, while still capable, to take decisions for foreseeable medical treatments for a time in the future when they may lack the capacity to consent to or refuse that treatment. At last, under a comparative point of view, the essay deals with the English stat…
Goserelin acetate to avoid hysterectomy in pre-menopausal women with fibroids requiring surgery
1999
Objective: To obtain information on the efficacy of repeated short cycles of GNRH agonist treatment in order to avoid hysterectomy in near-menopausal women with symptomatic fibroids. Study design: 72 pre-menopausal women (mean age 50 years) with one or more uterine fibroids >10 cm in diameter, symptomatic menorrhagia lasting three months or more and haemoglobin=9 g/dl entered the study. The patients were randomized with ratio of approximately 1:4 to: (a) immediate surgery; or (b) treatment with goserelin acetate. Patients randomized to goserelin acetate received a first cycle of 3.6 mg depot once every 28 days for four months. They were followed-up for three years. If menorrhagia was observ…